The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Targeted Disruption of NFATc3, but Not NFATc4, Reveals an Intrinsic Defect in Calcineurin-Mediated Cardiac Hypertrophic Growth
Open accessAbstract
A calcineurin-nuclear factor of activated T cells (NFAT) regulatory pathway has been implicated in the control of cardiac hypertrophy, suggesting one mechanism whereby alterations in intracellular calcium handling are linked to the expression of hypertrophy-associated genes. Although recent studies have demonstrated a necessary role for calcineurin as a mediator of cardiac hypertrophy, the potential involvement of NFAT transcription factors as downstream effectors of calcineurin signaling has not been evaluated. Accordingly, mice with targeted disruptions in NFATc3 and NFATc4 genes were characterized. Whereas the loss of NFATc4 did not compromise the ability of the myocardium to undergo hypertrophic growth, NFATc3-null mice demonstrated a significant reduction in calcineurin transgene-induced cardiac hypertrophy at 19 days, 26 days, 6 weeks, 8 weeks, and 10 weeks of age. NFATc3-null mice also demonstrated attenuated pressure overload- and angiotensin II-induced cardiac hypertrophy. These results provide genetic evidence that calcineurin-regulated responses require NFAT effectors in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
TRANSCRIPTION FACTORS OF THE NFAT FAMILY:Regulation and Function
Rao, A., Luo, C., & Hogan, P. G. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.707 · Cited by 2,603
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Self-citationLeft Ventricular Hypertrophy: Pathogenesis, Detection, and Prognosis
Lorell, B. H., & Carabello, B. A. (2000) · Circulation · doi:10.1161/01.cir.102.4.470 · Cited by 1,232
Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis.
Molkentin, J. D., Lin, Q., Duncan, S. A., & Olson, E. N. (1997) · Genes & Development · doi:10.1101/gad.11.8.1061 · Cited by 1,150
Self-citationNuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A
Flanagan, W. M., Corthésy, B., Bram, R. J., & Crabtree, G. R. (1991) · Nature · doi:10.1038/352803a0 · Cited by 1,056
Nuclear Export of NF-ATc Enhanced by Glycogen Synthase Kinase-3
Beals, C. R., Sheridan, C. M., Turck, C. W., Gardner, P., & Crabtree, G. R. (1997) · Science · doi:10.1126/science.275.5308.1930 · Cited by 754
Generic Signals and Specific Outcomes
Crabtree, G. R. (1999) · Cell · doi:10.1016/s0092-8674(00)80571-1 · Cited by 731
Cytoplasmic Signaling Pathways That Regulate Cardiac Hypertrophy
Molkentin, J. D., & Dorn II, G. W. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.391 · Cited by 689
Self-citationRole of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum
de la Pompa, J. L., Timmerman, L. A., Takimoto, H., Yoshida, H., Elia, A. J., Samper, E., Potter, J., Wakeham, A., Marengere, L., Langille, B. L., et al. (1998) · Nature · doi:10.1038/32419 · Cited by 660
The transcription factor NF-ATc is essential for cardiac valve formation
Ranger, A. M., Grusby, M. J., Hodge, M. R., Gravallese, E. M., de la Brousse, F. C., Hoey, T., Mickanin, C., Baldwin, H. S., & Glimcher, L. H. (1998) · Nature · doi:10.1038/32426 · Cited by 586
CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo
Passier, R., Zeng, H., Frey, N., Naya, F. J., Nicol, R. L., McKinsey, T. A., Overbeek, P., Richardson, J. A., Grant, S. R., & Olson, E. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8551 · Cited by 521
Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
Antos, C. L., McKinsey, T. A., Frey, N., Kutschke, W., McAnally, J., Shelton, J. M., Richardson, J. A., Hill, J. A., & Olson, E. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231619298 · Cited by 477
MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type
Wu, H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.9.1963 · Cited by 468
Prevention of Cardiac Hypertrophy in Mice by Calcineurin Inhibition
Sussman, M. A., Lim, H. W., Gude, N., Taigen, T., Olson, E. N., Robbins, J., Colbert, M. C., Gualberto, A., Wieczorek, D. F., & Molkentin, J. D. (1998) · Science · doi:10.1126/science.281.5383.1690 · Cited by 461
Self-citationHyperproliferation and Dysregulation ofIL-4 Expression in NF-ATp-Deficient Mice
Hodge, M. R., Ranger, A. M., de la Brousse, F. C., Hoey, T., Grusby, M. J., & Glimcher, L. H. (1996) · Immunity · doi:10.1016/s1074-7613(00)80253-8 · Cited by 444
NFATc1 and NFATc2 Together Control Both T and B Cell Activation and Differentiation
Peng, S. L., Gerth, A. J., Ranger, A. M., & Glimcher, L. H. (2001) · Immunity · doi:10.1016/s1074-7613(01)00085-1 · Cited by 418
Signals Transduced by Ca2+/Calcineurin and NFATc3/c4 Pattern the Developing Vasculature
Graef, I. A., Chen, F., Chen, L., Kuo, A., & Crabtree, G. R. (2001) · Cell · doi:10.1016/s0092-8674(01)00396-8 · Cited by 417
Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy
Haq, S., Choukroun, G., Kang, Z. B., Ranu, H., Matsui, T., Rosenzweig, A., Molkentin, J. D., Alessandrini, A., Woodgett, J., Hajjar, R., et al. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.1.117 · Cited by 392
Self-citationHoey, T., Sun, Y.-L., Williamson, K., & Xu, X. (1995) · Immunity · doi:10.1016/1074-7613(95)90027-6 · Cited by 390
NFAT5, a constitutively nuclear NFAT protein that does not cooperate with Fos and Jun
López-Rodríguez, C., Aramburu, J., Rakeman, A. S., & Rao, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7214 · Cited by 373
An Enhanced Immune Response in Mice Lacking the Transcription Factor NFAT1
Xanthoudakis, S., Viola, J. P. B., Shaw, K. T. Y., Luo, C., Wallace, J. D., Bozza, P. T., Luk, D. C., Curran, T., & Rao, A. (1996) · Science · doi:10.1126/science.272.5263.892 · Cited by 366
Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway
Wu, H. (2001) · The EMBO Journal · doi:10.1093/emboj/20.22.6414 · Cited by 365
[51] Gene targeting in embryonic stem cells
Ramírez-Solis, R., Davis, A. C., & Bradley, A. (1993) · Methods in Enzymology · doi:10.1016/0076-6879(93)25054-6 · Cited by 327
Inhibitory Function of Two NFAT Family Members in Lymphoid Homeostasis and Th2 Development
Ranger, A. M., Oukka, M., Rengarajan, J., & Glimcher, L. H. (1998) · Immunity · doi:10.1016/s1074-7613(00)80660-3 · Cited by 321
Cardiac hypertrophy is not a required compensatory response to short-term pressure overload
Hill, J. A., Karimi, M., Kutschke, W., Davisson, R. L., Zimmerman, K., Wang, Z., Kerber, R. E., & Weiss, R. M. (2000) · Circulation · doi:10.1161/01.cir.101.24.2863 · Cited by 309
Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy
Taigen, T., De Windt, L. J., Lim, H. W., & Molkentin, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.3.1196 · Cited by 294
Self-citationMyocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo
Rothermel, B. A., McKinsey, T. A., Vega, R. B., Nicol, R. L., Mammen, P., Yang, J., Antos, C. L., Shelton, J. M., Bassel-Duby, R., Olson, E. N., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041614798 · Cited by 294
The Transcription Factor NFAT4 Is Involved in the Generation and Survival of T Cells
Oukka, M., Ho, I.-C., de la Brousse, F. C., Hoey, T., Grusby, M. J., & Glimcher, L. H. (1998) · Immunity · doi:10.1016/s1074-7613(00)80612-3 · Cited by 267
Mende, U., Kagen, A., Cohen, A., Aramburu, J., Schoen, F. J., & Neer, E. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13893 · Cited by 258
Regulation of the Growth of Multinucleated Muscle Cells by an Nfatc2-Dependent Pathway
Horsley, V., Friday, B. B., Matteson, S., Kegley, K. M., Gephart, J., & Pavlath, G. K. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.2.329 · Cited by 256
Impaired cardiac hypertrophic response in Calcineurin Aβ -deficient mice
Bueno, O. F., Wilkins, B. J., Tymitz, K. M., Glascock, B. J., Kimball, T. F., Lorenz, J. N., & Molkentin, J. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072647999 · Cited by 237
Self-citationCalcineurin and Beyond: Cardiac Hypertrophic Signaling
Molkentin, J. D. (2000) · Circulation Research · doi:10.1161/01.res.87.9.731 · Cited by 229
Self-citationAn abnormal Ca2+ response in mutant sarcomere protein–mediated familial hypertrophic cardiomyopathy
Fatkin, D., McConnell, B. K., Mudd, J. O., Semsarian, C., Moskowitz, I. G. P., Schoen, F. J., Giewat, M., Seidman, C. E., & Seidman, J. G. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11093 · Cited by 228
Calcineurin Promotes Protein Kinase C and c-Jun NH2-terminal Kinase Activation in the Heart
De Windt, L. J., Lim, H. W., Haq, S., Force, T., & Molkentin, J. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13571 · Cited by 226
Self-citationIntegration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis
Youn, H.-D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.16.4323 · Cited by 223
Masuda, E. S., Naito, Y., Tokumitsu, H., Campbell, D., Saito, F., Hannum, C., Arai, K.-I., & Arai, N. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2697 · Cited by 216
Ca2+-dependent Gene Expression Mediated by MEF2 Transcription Factors
Blaeser, F., Ho, N., Prywes, R., & Chatila, T. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.197 · Cited by 203
Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo
De Windt, L. J., Lim, H. W., Bueno, O. F., Liang, Q., Delling, U., Braz, J. C., Glascock, B. J., Kimball, T. F., del Monte, F., Hajjar, R. J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.031371998 · Cited by 202
Self-citationJones, W. K., Grupp, I. L., Doetschman, T., Grupp, G., Osinska, H., Hewett, T. E., Boivin, G., Gulick, J., Ng, W. A., & Robbins, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118992 · Cited by 200
Ranger, A. M., Gerstenfeld, L. C., Wang, J., Kon, T., Bae, H., Gravallese, E. M., Glimcher, M. J., & Glimcher, L. H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.1.9 · Cited by 195
Meguro, T., Hong, C., Asai, K., Takagi, G., McKinsey, T. A., Olson, E. N., & Vatner, S. F. (1999) · Circulation Research · doi:10.1161/01.res.84.6.735 · Cited by 181
Mao, Z., & Wiedmann, M. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.31102 · Cited by 169
Cyclosporine A is an uncompetitive inhibitor of proteasome activity and prevents NF‐κB activation
Meyer, S., Kohler, N. G., & Joly, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00930-7 · Cited by 161
Calcineurin Expression, Activation, and Function in Cardiac Pressure-Overload Hypertrophy
Lim, H. W., De Windt, L. J., Steinberg, L., Taigen, T., Witt, S. A., Kimball, T. R., & Molkentin, J. D. (2000) · Circulation · doi:10.1161/01.cir.101.20.2431 · Cited by 158
Self-citationDing, B., Price, R. L., Borg, T. K., Weinberg, E. O., Halloran, P. F., & Lorell, B. H. (1999) · Circulation Research · doi:10.1161/01.res.84.6.729 · Cited by 153
Calcineurin Plays a Critical Role in Pressure Overload–Induced Cardiac Hypertrophy
Shimoyama, M., Hayashi, D., Takimoto, E., Zou, Y., Oka, T., Uozumi, H., Kudoh, S., Shibasaki, F., Yazaki, Y., Nagai, R., et al. (1999) · Circulation · doi:10.1161/01.cir.100.24.2449 · Cited by 149
Nonenzymatic separation of myocardial cell nuclei from whole heart tissue
Liew, C. C., Jackowski, G., Ma, T., & Sole, M. J. (1983) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1983.244.1.c3 · Cited by 146
Failure of Calcineurin Inhibitors to Prevent Pressure-Overload Left Ventricular Hypertrophy in Rats
Zhang, W., Kowal, R. C., Rusnak, F. M., Sikkink, R. A., Olson, E. N., & Victor, R. G. (1999) · Circulation Research · doi:10.1161/01.res.84.6.722 · Cited by 142
Altered Primary Myogenesis in NFATC3−/− Mice Leads to Decreased Muscle Size in the Adult
Kegley, K. M., Gephart, J., Warren, G. L., & Pavlath, G. K. (2001) · Developmental Biology · doi:10.1006/dbio.2001.0179 · Cited by 139
The Calcium/Calmodulin-dependent Protein Phosphatase Calcineurin Is the Major Elk-1 Phosphatase
Sugimoto, T., Stewart, S., & Guan, K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29415 · Cited by 135
Zou, Y., Hiroi, Y., Uozumi, H., Takimoto, E., Toko, H., Zhu, W., Kudoh, S., Mizukami, M., Shimoyama, M., Shibasaki, F., et al. (2001) · Circulation · doi:10.1161/01.cir.104.1.97 · Cited by 131
Structure of a TonEBP–DNA complex reveals DNA encircled by a transcription factor
Stroud, J. C., López‐Rodríguez, C., Rao, A., & Chen, L. (2002) · Nature Structural Biology · doi:10.1038/nsb749 · Cited by 127
Xia, Y., McMillin, J. B., Lewis, A. L., Moore, M. L. G., Zhu, W., Williams, R. S., & Kellems, R. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1855 · Cited by 122
Targeted Inhibition of Calcineurin in Pressure-overload Cardiac Hypertrophy
Hill, J. A., Rothermel, B. A., Yoo, K., Cabuay, B. M., Demetroulis, E., Weiss, R. M., Kutschke, W. J., Bassel‐Duby, R., & Williams, R. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110722200 · Cited by 119
Tian, J., & Karin, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.21.15173 · Cited by 107
Calcineurin Inhibition Attenuates Mineralocorticoid-Induced Cardiac Hypertrophy
Takeda, Y., Yoneda, T., Demura, M., Usukura, M., & Mabuchi, H. (2002) · Circulation · doi:10.1161/hc0602.104675 · Cited by 97
Na+-Ca2+ Exchanger Remodeling in Pressure Overload Cardiac Hypertrophy
Wang, Z., Nolan, B., Kutschke, W. J., & Hill, J. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100544200 · Cited by 94
Calcineurin inhibitors and cardiac hypertrophy
Luo, Z., Shyu, K.-G., Gualberto, A., & Walsh, K. X. (1998) · Nature Medicine · doi:10.1038/2578 · Cited by 92
Eto, Y., Yonekura, K., Sonoda, M., Arai, N., Sata, M., Sugiura, S., Takenaka, K., Gualberto, A., Hixon, M. L., Wagner, M. W., et al. (2000) · Circulation · doi:10.1161/01.cir.101.18.2134 · Cited by 88
Sakata, Y., Masuyama, T., Yamamoto, K., Nishikawa, N., Yamamoto, H., Kondo, H., Ono, K., Otsu, K., Kuzuya, T., Miwa, T., et al. (2000) · Circulation · doi:10.1161/01.cir.102.18.2269 · Cited by 84
Mervaala, E. M. A., Müller, D. N., Park, J.-K., Dechend, R., Schmidt, F. H., Fiebeler, A., Bieringer, M., Breu, V., Ganten, D., Haller, H. G., et al. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.360 · Cited by 74
Øie, E., Bjørnerheim, R., Clausen, O. P. F., & Attramadal, H. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.278.6.h2115 · Cited by 71
Sah, R., Oudit, G. Y., Nguyen, T.-T. T., Lim, H. W., Wickenden, A. D., Wilson, G. J., Molkentin, J. D., & Backx, P. H. (2002) · Circulation · doi:10.1161/01.cir.0000014211.47830.4d · Cited by 59
Self-citationShimoyama, M., Hayashi, D., Zou, Y., Takimoto, E., Mizukami, M., Monzen, K., Kudoh, S., Hiroi, Y., Yazaki, Y., Nagai, R., et al. (2000) · Circulation · doi:10.1161/01.cir.102.16.1996 · Cited by 50
Janssen, P. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00052-3 · Cited by 45
Deng, L., Huang, B., Qin, D., Ganguly, K., & El‐Sherif, N. (2001) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2001.01055.x · Cited by 42
Yang, G., Meguro, T., Hong, C., Asai, K., Takagi, G., Karoor, V., Sadoshima, J., Vatner, D. E., Bishop, S. P., & Vatner, S. F. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1413 · Cited by 36
Liu, J., Koyano‐Nakagawa, N., Amasaki, Y., Saito-Ohara, F., Ikeuchi, T., Imai, S., Takano, T., Arai, N., Yokota, T., & Arai, K. (1997) · Molecular Biology of the Cell · doi:10.1091/mbc.8.1.157 · Cited by 33
Cited by
Regulation of cardiac hypertrophy by intracellular signalling pathways
Heineke, J., & Molkentin, J. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1983 · Cited by 1,866
Self-citationCalcium Cycling and Signaling in Cardiac Myocytes
Bers, D. M. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100455 · Cited by 1,302
Bernardo, B. C., Weeks, K. L., Pretorius, L., & McMullen, J. R. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.04.005 · Cited by 894
Molecular Pathways Underlying Cardiac Remodeling During Pathophysiological Stimulation
Kehat, I., & Molkentin, J. D. (2010) · Circulation · doi:10.1161/circulationaha.110.942268 · Cited by 592
Self-citationTRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling
Kuwahara, K., Wang, Y., McAnally, J., Richardson, J. A., Bassel-Duby, R., Hill, J. A., & Olson, E. N. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27702 · Cited by 561
Metadata
- Authors
- Wilkins, B. J., De Windt, L. J., Bueno, O. F., Braz, J. C., Glascock, B. J., Kimball, T. F., & Molkentin, J. D.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2002-11-01
- Volume
- 22
- Issue
- 21
- Pages
- 7603-7613
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2103445003
- Cited by
- 262
- References
- 68
- FWCI
- 4.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.